Literature DB >> 20692331

Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.

Yongke Lu1, Defeng Wu, Xiaodong Wang, Stephen C Ward, Arthur I Cederbaum.   

Abstract

A major pathway for chronic ethanol-induced liver injury is ethanol-induced oxidant stress. Several pathways contribute to mechanisms by which ethanol induces oxidant stress. Although some studies support a role for cytochrome P450 2E1 (CYP2E1), others do not. Most previous studies were conducted in the intragastric infusion model of ethanol administration. There is a need to develop oral models of significant liver injury and to evaluate the possible role of CYP2E1 in ethanol actions in such models. We evaluated chronic ethanol-induced liver injury, steatosis, and oxidant stress in wild-type (WT) mice, CYP2E1 knock out (KO) mice, and humanized CYP2E1 knock-in (KI) mice, in which the human 2E1 was added back to mice deficient in the mouse 2E1. WT mice and the CYP2E1 KO and KI mice (both provided by Dr. F. Gonzalez, National Cancer Institute) were fed a high-fat Lieber-DeCarli ethanol liquid diet for 3weeks; pair-fed controls received dextrose. Ethanol produced fatty liver and oxidant stress in WT mice but liver injury (transaminases, histopathology) was minimal. Ethanol-induced steatosis and oxidant stress were blunted in the KO mice (no liver injury) but restored in the KI mice. Significant liver injury was produced in the ethanol-fed KI mice, with elevated transaminases, necrosis, and increased levels of collagen type 1 and smooth muscle actin. This liver injury in the KI mice was associated with elevated oxidant stress and elevated levels of the human CYP2E1 compared to levels of the mouse 2E1 in WT mice. Activation of JNK and decreased levels of Bcl-2 and Bcl-XL were observed in the ethanol-fed KI mice compared to the other groups. Fatty liver in the WT and the KI mice was associated with lower levels of PPARα and acyl-CoA oxidase. No such changes were found in the ethanol-fed KO mice. These results show that CYP2E1 plays a major role in ethanol-induced fatty liver and oxidant stress. It is the absence of CYP2E1 in the KO mice that is responsible for the blunting of steatosis and oxidant stress because restoring the CYP2E1 restores the fatty liver and oxidant stress. Moreover, it is the human CYP2E1 that restores these effects of ethanol, which suggests that results for fatty liver and oxidant stress from rodent models of ethanol intake and mouse CYP2E1 can be extrapolated to human models of ethanol intake and to human CYP2E1.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692331      PMCID: PMC2975513          DOI: 10.1016/j.freeradbiomed.2010.07.026

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  73 in total

1.  Introduction-serial review: alcohol, oxidative stress and cell injury.

Authors:  A I Cederbaum
Journal:  Free Radic Biol Med       Date:  2001-12-15       Impact factor: 7.376

2.  Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation.

Authors:  Ayman Koteish; ShiQi Yang; HuiZhi Lin; Xiawen Huang; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

3.  Gadolinium chloride reduces cytochrome P450: relevance to chemical-induced hepatotoxicity.

Authors:  D A Badger; R K Kuester; J M Sauer; I G Sipes
Journal:  Toxicology       Date:  1997-08-15       Impact factor: 4.221

4.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

5.  Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice.

Authors:  Y -J.Y. Wan; Y Cai; J Li; Q -X. Yuan; B French; F J. Gonzalez; S French
Journal:  Hepatol Res       Date:  2001-02       Impact factor: 4.288

6.  Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1.

Authors:  Go Fujino; Takuya Noguchi; Atsushi Matsuzawa; Shota Yamauchi; Masao Saitoh; Kohsuke Takeda; Hidenori Ichijo
Journal:  Mol Cell Biol       Date:  2007-08-27       Impact factor: 4.272

7.  The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.

Authors:  Angelica Butura; Kerstin Nilsson; Kengathevy Morgan; Timothy R Morgan; Samuel W French; Inger Johansson; Ina Schuppe-Koistinen; Magnus Ingelman-Sundberg
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

8.  Resveratrol alleviates alcoholic fatty liver in mice.

Authors:  Joanne M Ajmo; Xiaomei Liang; Christopher Q Rogers; Brandi Pennock; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

9.  Apoptosis and bcl-2 protein expression in experimental alcoholic liver disease in the rat.

Authors:  L K Yacoub; F Fogt; B Griniuviene; A A Nanji
Journal:  Alcohol Clin Exp Res       Date:  1995-08       Impact factor: 3.455

10.  Diallyl sulfide induces heme oxygenase-1 through MAPK pathway.

Authors:  Pengfei Gong; Bin Hu; Arthur I Cederbaum
Journal:  Arch Biochem Biophys       Date:  2004-12-15       Impact factor: 4.013

View more
  90 in total

1.  S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.

Authors:  Maria Lauda Tomasi; Ivan Tomasi; Komal Ramani; Rosa Maria Pascale; Jun Xu; Pasquale Giordano; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

Review 2.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

3.  Pharmacological blockage of CYP2E1 and alcohol-mediated liver cancer: is the time ready?

Authors:  Sebastian Mueller
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

4.  SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.

Authors:  Maria Lauda Tomasi; Komal Ramani; Minjung Ryoo; Carla Cossu; Andrea Floris; Ben J Murray; Ainhoa Iglesias-Ara; Ylenia Spissu; Nirmala Mavila
Journal:  FASEB J       Date:  2018-01-18       Impact factor: 5.191

5.  Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function.

Authors:  Qian Sun; Wenliang Zhang; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-09-12       Impact factor: 3.770

6.  Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

7.  Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats.

Authors:  Qinyuan Ye; Fuzhi Lian; Pollyanna R G Chavez; Jayong Chung; Wenhua Ling; Hua Qin; Helmut K Seitz; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2012-11-30       Impact factor: 7.293

8.  Alcohol steatosis and cytotoxicity: the role of cytochrome P4502E1 and autophagy.

Authors:  Defeng Wu; Xiaodong Wang; Richard Zhou; Lili Yang; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2012-07-20       Impact factor: 7.376

9.  Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  React Oxyg Species (Apex)       Date:  2016-03

Review 10.  Circadian rhythms, alcohol and gut interactions.

Authors:  Christopher B Forsyth; Robin M Voigt; Helen J Burgess; Garth R Swanson; Ali Keshavarzian
Journal:  Alcohol       Date:  2014-11-14       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.